Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Preclinical and clinical profile of Searle's fibrinogen antagonist

Nov. 10, 1997

TP-9201 covered by new U.S. patent

Nov. 10, 1997

Fibrinogen antagonists from Merck & Co.

Nov. 10, 1997

Spotlight on thrombin inhibitors

Nov. 10, 1997

ReoPro cleared in U.S. for expanded labeling

Nov. 7, 1997

Saruplase efficacy demonstrated in large patient study

Nov. 7, 1997

PEG-hirudin compared to established antithrombotic agents

Nov. 7, 1997

Akzo Nobel prepares two series of thrombin inhibitors

Nov. 7, 1997

Lefradafiban: oral prodrug for profound and sustained inhibition of platelet aggregation

Nov. 5, 1997

Teijin licenses new thrombolytic from Schering AG

Nov. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest
BioWorld
A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
Pleased to own ya, Kelonia: Lilly’s $7B CAR T deal
BioWorld
The already-thriving CAR T space took another big stride forward as Eli Lilly and Co. disclosed its plan to acquire Boston-based Kelonia Therapeutics Inc. for as...